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Abstract. 
 
We show that specific mutations in the head 
of the thick filament molecule myosin heavy chain pre-
vent a degenerative muscle syndrome resulting from 
 
the 
 
hdp
 
2
 
 mutation in the thin filament protein troponin 
I. One mutation deletes eight residues from the actin 
binding loop of myosin, while a second affects a residue 
at the base of this loop. Two other mutations affect 
amino acids near the site of nucleotide entry and exit in 
the motor domain. We document the degree of pheno-
typic rescue each suppressor permits and show that 
other point mutations in myosin, as well as null muta-
tions, fail to suppress the 
 
hdp
 
2
 
 phenotype. We discuss 
mechanisms by which the 
 
hdp
 
2
 
 phenotypes are sup-
pressed and conclude that the specific residues we iden-
tified in myosin are important in regulating thick and 
thin filament interactions. This in vivo approach to dis-
secting the contractile cycle defines novel molecular 
processes that may be difficult to uncover by biochemi-
cal and structural analysis. Our study illustrates how ex-
pression of genetic defects are dependent upon genetic 
background, and therefore could have implications for 
understanding gene interactions in human disease. 
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M
 
USCLE
 
 contraction is the result of a series of
protein–protein interactions and conformational
changes that culminate in ATP-dependent move-
ment of the myosin head of the thick filament when it is
attached to actin of the thin filament. The action of the
myosin head slides the thin filament relative to the thick
filament, causing sarcomere shortening. Thin filaments
are normally inhibited from interacting with thick fila-
ments due to blockage of the myosin binding sites on actin
by a strand of tropomyosin molecules, and possibly by the
troponin I protein of the thin-filament based troponin
complex. The inhibition is relieved by release of calcium
 
ions from internal stores following neural activity. Ca
 
2
 
1
 
binds to troponin C protein, reconfiguring the troponin
T–based interaction of the entire troponin complex with
tropomyosin. The resulting movement of the tropomyosin
strand from its inhibitory position permits the myosin
crossbridge to bind to the thin filament. For a recent re-
view, see Squire (1997).
There are numerous conformational rearrangements in-
volved in thin-filament regulation of the crossbridge cycle
(Farah and Reinach, 1995). Multiple Ca
 
2
 
1
 
-induced changes
in interaction among subunits of the troponin complex and
between troponin and tropomyosin occur, although the
details of the structural role of the troponin complex in
this regulation are not known. Not only does tropomyosin
 
shift during Ca
 
2
 
1
 
 activation of the thin filament, but the
actin monomer changes conformation (al-Khayat et al.,
1995). Further, binding of the myosin head to the thin fila-
ment is a cooperative process that involves progressive
tropomyosin movement (Vibert et al., 1997). The first my-
osin heads bind weakly to actin and interact with tropomy-
osin to push it further away from myosin binding sites on
actin. This leads to a decreased duration of the ATP cycle,
i.e., a fully on state (McKillop and Geeves, 1993; Metzger,
1995). Understanding the details of the contractile cycle is
important for defining the mechanisms of human diseases,
such as familial hypertrophic cardiomyopathy, where mu-
tations in a number of sarcomeric contractile proteins can
result in aberrant contractile properties and muscle hyper-
trophy (Watkins et al., 1995; Towbin, 1998).
Some success in mapping precise interaction sites of var-
ious contractile apparatus components has resulted from
electron microscopy/image reconstruction, and from bio-
chemical assays that assess interaction between intact pro-
teins, proteolytic fragments, and expressed recombinant
peptides. These studies are supplemented by determina-
tions of atomic structure of contractile proteins that indi-
cate the location of putative binding sites in particular
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conformational states. For instance, it has been shown re-
cently that an NH
 
2
 
-terminal 
 
a
 
-helical region of troponin I
binds to troponin C at low Ca
 
2
 
1
 
 conditions (Vassylyev et
al., 1998). It is proposed that Ca
 
2
 
1
 
 binding to troponin C
releases this troponin I region and allows binding of an in-
hibitory region of troponin I, thereby allowing actomyosin
interaction (Tripet et al., 1997; Vassylyev et al., 1998). It is
important to note, however, that in vitro approaches rep-
resent a trade off between structural resolution and biolog-
ical significance of derived conclusions. The inhibitory role
of troponin I is a case in point. Inhibitory properties have
been ascribed to the fragment between residues 104–115.
However, this fragment’s inhibiting efficiency is lower than
the entire 1–116 fragment and this, in turn, is less inhibitory
than the whole molecule (Tripet et al., 1997; Van Eyk et
al., 1997).
An alternative method to assessing functional interac-
tions of proteins during the contractile cycle involves ge-
netic analysis, i.e., disrupting muscle function by mutating
a particular contractile protein and searching for suppres-
sor mutations that restore function. This is a particularly
powerful approach in that interactions relevant to muscle
function in vivo are clarified. In principle, suppressor mu-
tations reveal sites of specific protein–protein interactions
that are important to myofibril assembly and/or function.
It is also possible that suppressor mutations work by less
direct mechanisms, such as through interactions with an
intermediary component of the contractile apparatus, or
by a general change in protein function that compensates
for the original mutation in a less specific way. The sup-
pressor mutation approach has been applied most success-
fully to mapping muscle protein interactions in 
 
Caenorhab-
ditis elegans
 
 (Greenwald and Horvitz, 1982; Moerman et
al., 1982; Park and Horvitz, 1986; Gengyo-Ando and Ka-
gawa, 1991).
Prado et al. (1995) described the isolation of suppressor
mutations in 
 
Drosophila melanogaster
 
 for a particular
point mutation of troponin I, the inhibitory subunit of the
troponin complex. These suppressors prevent the heldup
wings phenotype that arises from severe defects in the in-
direct flight muscles of the troponin I mutant. One sup-
pressor is within the mutated troponin I protein itself
(Prado et al., 1995). Four others are mapped to the second
chromosome. Determination of mutant gene(s) that act to
suppress troponin I defect, and definition of the precise lo-
cation of mutations should reveal protein–protein interac-
tions important to muscle function in vivo.
In this paper, we show that the four genetic suppressors
of a 
 
Drosophila
 
 troponin I point mutation are within the
myosin heavy chain (MHC)
 
1
 
. We determine molecular al-
terations in the myosin molecule and map these on the
three-dimensional structure of globular head in an effort
to understand the molecular basis of suppression. We
show that observed suppression is allele-specific, i.e., it is
dependent on a specific mutated residue in troponin I and
particular sites within MHC. We elucidate the degree of
phenotypic suppression observed in indirect flight muscles
of adult flies using light and electron microscopy, and
demonstrate that different myosin suppressor alleles sup-
 
press the troponin defects to different degrees. Finally, we
discuss the possibility that our work reveals an interaction
between MHC and troponin I, a prospect not previously
proposed based on structural or biochemical studies.
 
Materials and Methods
 
Isolation, Mapping, and Sequencing of
Suppressor Mutations
 
Isolation of dominant suppressors of 
 
heldup
 
2
 
 was described in Prado et al.
(1995). In brief, adult 
 
hdp
 
2
 
 males were mutagenized with ethyl-methane
sulfonate (EMS) according to standard procedures, and crossed to fe-
males of the genotype 
 
C(1)M3/Y
 
;
 
Sco/CyO
 
 or 
 
C(1)M3/Y
 
;
 
TM1/TM3
 
. Male
offspring with near normal wing position, instead of the expected heldup
wings, were crossed individually to balancer stocks to identify the chromo-
some containing the suppressor. Stocks with a series of recessive markers
were used to determine the map position of each suppressor on a particu-
lar chromosome based upon recombination between markers. Each iso-
lated suppressor should be designated as 
 
Su(hdp
 
2
 
)D
 
 followed by an iden-
tification number. For brevity, they are referred to as 
 
D
 
 mutations in the
text. As per standard practice, gene abbreviations are designated in italics
and proteins are in capital Roman type.
We obtained recessive–lethal, homozygous suppressor strain embryos
for DNA amplification and sequencing by using a second chromosome
balancer line 
 
(CyO y
 
1
 
)
 
 marked with the 
 
yellow
 
1
 
 gene (
 
y
 
1
 
; Mardahl et al.,
1993) in combination with an X chromosome marked with the 
 
y
 
 and 
 
w
 
(white eye) mutations. To this end, 
 
hdp
 
2
 
;
 
D
 
 mutation/
 
CyO
 
 males were
mated with 
 
y w
 
;
 
CyO y
 
1
 
/Bc Elp
 
 females. Male offspring of genotype 
 
y w
 
;
 
D
 
mutation/
 
CyO y
 
1
 
 were backcrossed to 
 
y w
 
;
 
CyO y
 
1
 
/Bc
 
 
 
Elp
 
 females. Re-
sulting males and females of the 
 
y w
 
;
 
D
 
 mutation/
 
CyO y
 
1
 
 genotype were
mated to produce a stable stock. Embryos with dark mouth hooks carry
one or two copies of the second chromosome marked with 
 
CyO y
 
1
 
, while
homozygotes for the 
 
D
 
 suppressor mutation display yellow mouth hooks.
Genomic DNA was extracted from homozygous embryos of each sup-
pressor mutant according to the method of Jowett (1986). 60 embryos
were frozen in an Eppendorf tube and stored at 
 
2
 
80
 
8
 
C for at least 1 h.
40 
 
m
 
l of single fly homogenization buffer (10 mM Tris-HCl, pH 7.5, 60 mM
NaCl, 50 mM EDTA, 150 
 
m
 
M spermine, 150 
 
m
 
M spermidine) were added
and the samples were ground with a plastic pestle. 40 
 
m
 
l of single fly lysis
buffer (1.25% [wt/vol] SDS, 300 mM Tris-HCl, pH 8, 100 mM EDTA, 5%
[wt/vol] sucrose, 0.75% freshly added diethyl pyrocarbonate) were added.
The mixture was incubated for 30 min at 60
 
8
 
C. The sample was cooled to
room temperature and 12 
 
m
 
l of 8 M potassium acetate was added. After
cooling on ice for 45 min, debris was pelleted by 1 min centrifugation in a
microfuge. Supernatant was removed to a fresh tube and 200 
 
m
 
l of 100%
ethanol was added. DNA was precipitated at room temperature for 10
min and pelleted in a microfuge for 10 min. The sample was washed with
80% ethanol and vacuum dried. The pellet was resuspended in 60 
 
m
 
l TE
(10 mM Tris-HCl, pH 8, 1 mM EDTA).
Genomic DNA from each mutant was used in PCR to generate 11 frag-
ments that cover the entire coding region, plus flanking introns of the 
 
Mhc
 
gene. The following oligonucleotide primers were used for amplification
(sequences given for noncoding strand in a 5
 
9
 
 to 3
 
9
 
 orientation): 1, ATGC-
CGAAGCCAGTCGCAAAT (position 1924), GGAATTCGATACG-
GATGAATTTACC (position 4141); 2, TAAGCTTGAAGACCGAT-
GAGGCC (position 3948), ATAGCCGTCACTACATAGAGC (position
5941); 3, TTATGTTCTTCTTGCTAAACC (position 6456), ATCTGAC-
TAAAATCCTCAGA (position 8185); 4, GATACACTGCAGCAC-
TAT (position 8367), TGATCGGAGGCCTTGGGGAAC (position
10131); 5, GTTCCCCAAGGCCTCCGATCA (position 10131), GTG-
TGGGGATTCAATTGAAAG (position 11087); 6, GGAATCAA-
AAACGAACTCTAC (position 11206), CTAATTGTGGAAGGAGC
(position 11818); 7, GTTAAGATCAACTGTAACTAA (position 12206),
AGACCCAGGCTGGTCTCGTT (position 14095); 8, CTTCAGCCC-
GAATCGACCGCC (position 15455), TCAGATCTCTCTATCTCGAT
(position 16958); 9, TTGAAGGATCTACAGTTTACA (position 16959),
GGGTGACAGACGCTGCTTGGT (position 18365); 10, GTCCCAG-
GTGTCTCAGCTGT (position 18045), GGCGGGCGGCATCGACCA-
TAG (position 19512); and 11, TGCGTCGTGAGAACAAGAACC (po-
sition 18653), TATTACTCTCTTGTTTT (position 20368). Each PCR
sample contained 5 
 
m
 
l of genomic DNA, 20 
 
m
 
l of 10
 
3
 
 PCR buffer
(Promega Corp.), 20 
 
m
 
l of 5 
 
m
 
M solutions of each dNTP (80 
 
m
 
l total), 16 
 
m
 
l
 
1.
 
 Abbreviations used in this paper:
 
 
 
D
 
,
 
 Su(hdp
 
2
 
)D
 
;
 
 
 
DLM, dorsolongitudi-
nal muscle; MHC, myosin heavy chain; 
 
Mhc
 
, myosin heavy chain gene.
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of 25 mM MgCl
 
2
 
, 100 pmol each of two primers, 0.8 
 
m
 
l of Taq polymerase
(Promega Corp.), and was brought to a total volume of 200 
 
m
 
l with dis-
tilled H
 
2
 
O. Paraffin oil was placed on top of the sample to prevent evapo-
ration, and DNA was amplified in an Ericomp thermocycler as follows:
one cycle at 95
 
8
 
C for 1 min, 45
 
8
 
C for 2 min, 72
 
8
 
C for 40 min; 28 cycles at
95
 
8
 
C for 1 min, 45
 
8
 
C for 2 min, 72
 
8
 
C for 6 min; and one cycle at 95
 
8
 
C for 1
min, 45
 
8
 
C for 2 min, 72
 
8
 
C for 15 min. Paraffin oil was then removed and
DNA was chloroform extracted and precipitated.
PCR products were cloned before sequencing. Amplified products
were separated by agarose gel electrophoresis, isolated using GeneClean
(Bio 101), and blunt ends were created with the Klenow fragment of
 
Escherichia coli
 
 DNA polymerase I (Sambrook et al., 1989). Each fragment
was cloned into the EcoRV site of pKS plasmid (Stratagene) and DNA se-
quencing was performed using a Sequenase kit (United States Biochemi-
cals) or on an automated DNA sequencer (Applied Biosystems).
 
Reverse Transcription and Amplification of
Mhc mRNA
 
First strand synthesis of cDNA was performed using 1 
 
m
 
g of total RNA
(isolated as described in Hess and Bernstein, 1991), 100 pmol of 3
 
9
 
 primer
(TGATCGGAGGCCTTGGGGAAC, position 10131), 1.4 
 
m
 
l of 5
 
3
 
 first
strand buffer (250 mM Tris, pH 8.5, 375 mM KCl, 5 mM MgCl
 
2
 
, 50 mM
dithiothreitol), brought to a total volume of 7 
 
m
 
l with distilled H
 
2
 
O. The
mixture was placed in boiling water for 30 s, then allowed to cool to 37
 
8
 
C.
1 
 
m
 
l of Inhibitase (1 U/
 
m
 
l; Promega Corp.) was then added along with 0.5 
 
m
 
l
of each dNTP at 10 mM. Then 0.6 
 
m
 
l of 5
 
3
 
 first strand buffer was added
plus 0.5 
 
m
 
l of distilled H
 
2
 
O. The reaction was started by addition of 1.0 
 
m
 
l
of M-MLv reverse transcriptase (100 U/
 
m
 
l; GIBCO BRL) and the sample
was incubated at 37
 
8
 
C for 1.5 h. The reaction was terminated on ice by
adding 20 
 
m
 
l of 0.3 M NaOH/0.03 M EDTA. RNA was hydrolyzed at 60
 
8
 
C
for 1 h. The solution was neutralized by adding 3.4 
 
m
 
l of 3 M sodium ace-
tate, pH 5.2, and cDNA was precipitated with 2.5 vol of 100% ethanol. Af-
ter centrifugation in the microfuge for 15 min at 4
 
8
 
C, the DNA pellet was
washed with 80% ethanol and vacuum dried. The sample was resus-
pended in 10 
 
m
 
l distilled H
 
2
 
O. Half the sample was amplified using the
3
 
9
 
 primer at position 10131 and 5
 
9
 
 primer GGCTGGTGCTGATAT-
TGAGA (position 4182), as described for genomic DNA above.
 
In Situ Hybridization
 
Slides were cleaned by thorough washing with liquid hand soap, then
treated with subbing solution (0.5% gelatin, 0.05% chrome alum). Slides
were dried overnight in a dust-free environment. Tissue was prepared by
embedding whole flies (with wings removed) in OCT compound and
freezing on dry ice. Frozen tissue sections (8–16 
 
m
 
m) were taken using a
microtome. These were placed onto treated slides and allowed to dry. Tis-
sue was fixed with 4% paraformaldehyde for 20 min and then washed
three times in 1
 
3
 
 PBT (1.3 M NaCl, 0.07 M Na
 
2
 
HPO
 
4
 
, 0.03 M NaH
 
2
 
PO
 
4
 
,
1% Tween 20). Sections were then treated with 50 
 
m
 
g/ml proteinase K in
PBT for 3 min. This was followed by treatment with 2 mg/ml glycine in
PBT for 1 min (repeated once). Slides were washed in PBS (1.3 M NaCl,
0.07 M Na
 
2
 
HPO
 
4
 
, 0.03 M NaH
 
2
 
PO
 
4
 
) for 1 min and placed in 4%
paraformaldehyde for 20 min. This was followed by two washes with PBS
for 5 min each. The samples were dehydrated in 30% ethanol, 50% etha-
nol, 70% ethanol, 80% ethanol, 95% ethanol, 100% ethanol (5 min each),
and placed under the vacuum for 40 min.
Transcription of digoxigenin-labeled probes was according to the pro-
cedure provided in Genius 3 Kit (Boehringer Mannheim). Antisense
probes from each copy of exon 7 were prepared from the following frag-
ments that had been cloned into a plasmid containing a T3 or T7 RNA
polymerase binding site: exon 7a, XbaI (4568) to HindIII (4940); exon 7b,
HindIII (4940) to HindIII (5300); exon 7c, Hind III (5300) to EcoRV
(5900); exon 7d, EcoRV (5900) to EcoRI (6600). 1 mg of RNA probe was
added to 25 ml of 10 mg/ml tRNA and brought to a total volume of 100 ml
with distilled H2O. The probe was denatured by heating at 758C for
10 min.
Hybridization was carried out by adding the denatured probe to 400 ml
of hybridization buffer (50% formamide, 10% dextran sulfate, 0.3 M
NaCl, 10 mM Tris-HCl, pH 8, 1 mM EDTA, 0.1% Tween 20, 50 mg/ml hep-
arin, 13 Denhardt’s solution). 100 ml of the probe in hybridization solu-
tion were placed onto each slide. Slides were covered with a plastic sealer
(HybriWell, Research Products International) and placed in a sealed box.
Hybridization was allowed to proceed for at least 18 h at 568C.
After hybridization, slides were washed with 43 SSC (twice for 10 min
each). This was followed by RNase A treatment (20 mg/ml in 0.5 M NaCl,
10 mM Tris, pH 7.5, 1 mM EDTA) to remove single-stranded probe for 30
min at 378C. Slides were washed in PBT for 5 min (repeated once), and
then incubated with antibody conjugate at a ratio of 1:500 in PBT plus 5%
normal goat serum for 120 min. Unbound antibody was washed off with
buffer 3 (100 mM Tris, pH 9.53, 100 mM NaCl, 50 mM MgCl2) for 5 min.
This was repeated. Color reaction buffer was prepared by adding 20 ml of
buffer 3 to 100 ml of NBT and 75 ml of X phosphate. This reaction was al-
lowed to proceed for at least 1 h and as long as overnight. The reaction
was stopped by rinsing in H2O.
Protein Analysis
One-dimensional SDS-PAGE was performed by the method of Laemmli
(1970). Upper thoraces from 10 flies were dissected, homogenized in 100 ml
sample buffer and boiled. Samples (10 ml) were loaded on gels containing
9.5% acrylamide. After staining in Coomassie blue, scanning was per-
formed using a Molecular Dynamics densitometer. MHC levels were nor-
malized to actin levels within the same lane to account for differences in
protein loading levels.
Flight Testing
Flight testing was performed using the method of Drummond et al. (1991)
on young (2-d-old flies).
Microscopy
For transmission electron microscopy, flies were dissected according to
the protocol of Peckham et al. (1990). Once the heads, wings, and ab-
domens were removed, thoraces were fixed overnight at 48C in 4%
paraformaldehyde, 1% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2.
The dorsolongitudinal muscles (DLMs) were dissected from the thoraces,
washed several times in buffer, and postfixed in 2% OsO4 in buffer for 45
min at 48C in the dark. After dehydration, DLMs were embedded in
Araldite resin. Silver sections (60–70 nm) were cut on a Reichert Ultracut
E ultramicrotome, collected on Formvar-coated grids, and counterstained
with uranyl acetate (10 min) and lead citrate (10 min). Micrographs were
obtained using a JEOL 1200 EX electron microscope. Morphological
analysis at the light microscope level was carried out on paraffin-embed-
ded samples stained with Toluidine blue (Prado et al., 1995).
Results
Phenotypic Analysis of Dorsolongitudinal Muscles in 
Normal Flies and heldup2 Troponin I Mutants
The DLMs are composed of six fibers (a–f) attached to the
anterior and posterior sides of the thorax (Fig. 1 A). The
DLM fibers, like the opposing dorsoventral indirect flight
muscles, are termed fibrillar muscles. This is because each
fiber contains several hundred myofibrils that can be eas-
ily teased apart. Individual fibrils are subdivided by trans-
verse bands of electron dense material, the Z bands, that
define the unit of contraction, the sarcomere (Fig. 1 B). In
a transverse view, the circular fibril contains a crystalline-
like array of thick and thin filaments that is arranged in a
1:6 hexagonal pattern (Fig. 1 C). In the normal strain used
here, Canton-S (CS), z1,000 thick and 2,000 thin filaments
accumulate in each fibril. These numbers are fairly con-
stant within a muscle showing only a 5% variability in
DLM muscle (a) of our CS stock. Note, however, that
other normal strains may exhibit up to 1,500 thick fila-
ments per fibril.
In the troponin I mutant heldup2, the six DLMs appear
torn apart from the center (Fig. 1 D). In the remaining
muscle material, near the attachment sites, the sarcomere
length is 40% reduced and the thick–thin filament pattern is
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destroyed mostly due to the collapse of thin filaments (Fig.
1, E and F). It appears as if the mutant muscles were
clamped in a state of hypercontraction. The mutation hdp2
is a single amino acid change, Ala55Val, affecting all known
isoforms of troponin I (Beall and Fyrberg, 1991; our un-
published data). This corresponds to residue 25 in rabbit
skeletal muscle troponin I (see Vassylyev et al., 1998).
D Suppressors on Chromosome II are Mhc Mutations
To identify molecular interactions between muscle pro-
teins and troponin I, we screened for mutations that sup-
press the heldup wing position of the troponin I hdp2 mu-
tation and isolated four D mutations that map to
chromosome II (Prado et al., 1995). We employed meiotic
recombination to discern their locations on the second
chromosome, and found they map between markers rd
and pr. Further, we localized recessive lethality associated
with mutations D41, 45, and 62 to the interval uncovered
by Df(2)H20. This deficiency removes polytene chromo-
some regions 36A8–36A9;36F1 and contains the myosin
heavy chain (Mhc) gene.
To determine whether the suppressor mutations are
Mhc alleles, we performed genetic complementation tests
with known Mhc alleles (for details on these alleles, see
Lindsley and Zimm, 1992). We crossed each of the D-sup-
pressor mutants to a null mutant (Mhc1), a hypomorphic
mutant (Mhc2), and several point mutants (Mhc5, Mhc6,
Mhc8). Mhc1, Mhc2, and Mhc8 are recessive lethal alleles,
while Mhc5 and Mhc6 are viable as homozygotes. Our re-
sults show that the D-suppressor mutants are likely to be
Mhc alleles, since none of the suppressors produced prog-
eny over Mhc null or hypomorphic alleles, except for D1
which occasionally was viable in combination with Mhc1.
The suppressors produced viable progeny in combination
with the various point mutations, except that D1 is lethal
in combination with Mhc5, D41 is lethal with Mhc8, and
D62 produces very few viable adults in combination with
Mhc8. These data demonstrate interaction, and likely allel-
ism, between the D-suppressor mutants and Mhc.
Since Mhc null alleles are recessive lethal (O’Donnell
and Bernstein, 1988), as are three of the four D-series sup-
pressor mutants, it is important to determine whether the
latter exert their suppression effect through failure to ac-
cumulate MHC. We determined whether MHC protein accu-
mulates in the suppressor strains by crossing each to Mhc10
and measuring MHC levels in upper thoraces of heterozy-
gotes. Mhc10 adults fail to accumulate MHC in the jump
and indirect flight muscles due to a mutation in an alterna-
tive exon specifically used in these muscle types (O’Don-
nell et al., 1989). Each of the D/Mhc10 heterozygotes accu-
mulate more MHC than Mhc10/Mhc10 adults, but less than
1/Mhc10 individuals (Table I). This indicates that suppres-
sor mutations produce stable MHC protein. While the
suppressor mutants accumulate only z65–85% as much
MHC as flies carrying one copy of wild-type Mhc gene, it
Figure 1. Normal and heldup2 mutant
dorsolongitudinal muscles (DLM). (A)
Diagram showing the six (a–f) DLM fi-
bers in a sagittal view. Anterior is to
the left, and dorsal is up. (B) Detail of
a fibril showing a sarcomere between Z
bands and including an M line. (C)
Transverse view of a fibril showing the
1:6 array of thick to thin filaments. The
square box has one thick filament in
the center and six surrounding thin fil-
aments in a hexagonal pattern. (D)
Sagittal section of a hdp2 male. Note
the remnants of the six DLMs near
their attachment sites. (E) Hypercon-
tracted sarcomeres in which the M line
is no longer detected. (F) Cross section
of a mutant muscle in which only thick
filaments are visible. Bar: (A) 250 mm;
(B and E) 750 nm; (C and F) 120 nm;
(D) 240 mm.
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is clear that suppressor alleles are not null mutations for
Mhc. It is also noteworthy that Mhc missense mutations
that cause flight muscle dysfunction typically result in less
than wild-type levels of MHC accumulation (Mogami et al.,
1986; Kronert et al., 1995).
To demonstrate that each suppressor mutation resides
within Mhc, and to determine their molecular lesions, we
cloned and sequenced the Mhc gene from homozygous
embryos of each strain. We found that each suppressor
strain has a discrete region of the Mhc coding sequence al-
tered, and all mutations affect the head domain (S1 frag-
ment) of the myosin molecule. We mapped encoded aber-
rations onto the three-dimensional map of chicken myosin
head (Fig. 2). Amino acid identity between Drosophila
and chicken myosin is high, and the atomic resolution crys-
tal structure of the chicken molecule (Rayment et al.,
1993b) serves as an excellent model for visualizing Dro-
sophila alternative coding regions and mutations (Bernstein
and Milligan, 1997).
D1 is a point mutation in exon 10 (Afi G), changing
amino acid 625 (chicken MHC numbering system) from
Asp to Gly (Table I). This mutation affects an amino acid
at the base of the second loop of the molecule (Fig. 2).
This loop is involved in actin binding (Mornet et al., 1981;
Sutoh, 1982; Rayment et al., 1993a,b; Uyeda et al., 1994;
Rovner et al., 1995). If the mutation affects the mobility of
the loop, it could dampen acto-myosin interaction.
Mutation D62 also affects exon 10, and is a 24-bp in-
frame deletion starting at amino acid 638 (Table I). Like
D1, this mutation affects the loop that binds actin. It re-
moves eight amino acids within the loop and clearly would
be expected to affect actomyosin interaction. The loop,
which runs from residue 627 to 646, is not visible in Fig. 2
due to its flexible nature (Rayment et al., 1993b).
Mutation D45 is a point mutation in exon 5 (Gfi A),
changing amino acid 261 from Ala to Thr (Table I). This
amino acid is in the general vicinity of ATP entry and the
ATP binding site (Fig. 2). However, it is on the surface of
the molecule, away from direct interactions with the nucle-
otide. It is located very close to loop 1 of the molecule
(residues 204–216), which is not visible in the structure.
This loop is important for regulating nucleotide entry and
exit from the ATP binding pocket (Murphy and Spudich,
1998; Sweeney et al., 1998).
Mutation D41 is a 2-bp insertion into exon 7a, interrupt-
ing amino acid codon 328. It places this alternative exon
out of frame and inserts a stop codon (Table I). The muta-
tion also produces a potential 59 splice junction, GTA-
GCT. This could disrupt alternative splicing. To study
this, we used RT-PCR to amplify the exon 7 region in
adult upper thoraces from this mutant. Since this muta-
tion is recessive lethal, the thoraces were taken from
D41/Mhc10 organisms (note that Mhc10 RNA fails to ac-
cumulate in fly thoraces due to a splicing defect; Collier
et al., 1990). We cloned the PCR products from D41/
Mhc10 heterozygotes and analyzed a number of clones by
DNA sequencing or restriction enzyme digestion. Nor-
mally exon 7d is used in indirect flight muscles (Hastings
and Emerson, 1991), which make up the bulk of the tho-
rax. We found this to be the case in all 17 clones analyzed
from wild-type thoraces. However, we observed an ex-
treme reduction in exon 7d usage, replaced by in-frame in-
clusion of exons 7b or 7c, in clones of Mhc PCR products
from thoraces of D41/Mhc10 organisms (1 exon 7b, 13 exon
7c, and 4 exon 7d). Thus, the insertion of a splice junction
in exon 7a appears to disrupt the alternative splicing pro-
cess.
We next used in situ hybridization to investigate the
possibility of tissue-specific alternative splicing disruption
in thoracic musculature of D41 adults. Alternative exon-
specific probes were prepared and hybridized to sections
of young adults, either wild-type or D41/Mhc10 mutant.
The hybridization results clearly showed that exon 7d ac-
cumulates in indirect flight muscles of wild-type, but is be-
Table I. Genetic and Molecular Properties of the D-series Suppressors and Other Mhc Alleles
Mhc genotype Lethal over Mhc null Protein* Wild-type sequence Mutant sequence‡
%
D1 no 73 Asp Gly (aa 625)
GAT GGT
D41 yes 65 AspAspAlaGlu AspGluStop----
GATGATGCTGAG GATGAGTAGCTGAG
[changes aa 328, creates stop 
codon, 59 splice site (underlined)]
D45 yes 85 Ala Thr (aa 261)
GCT ACT
D62 yes 77 GlyGlyArgGlyLysLysGlyGlyGlyPhe GlyPhe
GGAGGTCGTGGCAAGAAGGGCGGTGGCTTC GGCTTC
(deletion in D62 underlined) (deletion of aa 638-645)
Mhc5 no 88 Gly Asp (aa 200)
GGT GAT
Mhc6§ no 90-100 Arg His (MHC rod)
CGC CAC
Mhc8 yes 79i Tyr His (aa 832)
TAC CAC
*Protein levels of MHC standardized to actin levels and expressed as a percentage of wild-type MHC accumulation.
‡Chicken amino acid sequences given to allow localization on the chicken myosin S1 structure. 
§Data from Kronert et al. (1995).
iProtein accumulation data from Mogami et al. (1986).
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low detectable levels in D41 indirect flight muscles (Fig.
3). High levels of exon 7c accumulate in D41 indirect flight
muscles, but no trace of this exon is detected in wild-type
indirect flight muscle transcripts. Thus, the unusual effect
of the mutation is to disrupt the alternative splicing appa-
ratus through the introduction of a 59 splice site, resulting
in use of a different alternative exon than is normally em-
ployed in indirect flight muscles. Exon 7 encodes a region
at the lip of the nucleotide binding pocket (light blue in
Fig. 2). It is possible that using the wrong version of this al-
ternative exon disrupts MHC function by changing nucle-
otide affinity and disrupting the ATPase cycle.
Figure 2. Locations of muta-
tions on the three-dimen-
sional structure of the myosin
head. The figure depicts a
stereo-pair image of the
atomic resolution structure of
chicken myosin S1 (Rayment
et al., 1993b) with regions
encoded by Drosophila alter-
native exons and Drosoph-
ila Mhc mutations superim-
posed. The backbone of the
heavy chain is yellow, the es-
sential light chain is green,
and the regulatory light chain
is red. The location of the
b-phosphate group of ATP is
shown as a red sphere, with
the reactive thiols depicted
as tricolored residues. The
Drosophila MHC regions en-
coded by alternative exons
are purple (exon 3), light blue
(exon 7), dark blue (exon 9),
and tan (exon 11; Bernstein
and Milligan, 1997). Two
hdp2 suppressor mutations
are at the actin binding loop.
Mutation D1 affects residue
625 at the base of the loop
while mutation D62 is an 8
amino acid deletion in the
loop itself. The loop is not
visible in the structure due to its flexible nature, but its ends are located behind residue 625 and at the terminus of a long helical struc-
ture just to its right. Mutation D45 is at residue 261, on the surface of the molecule. This residue is just to the right of the two free ends
of the molecule representing the flexible loop at the lip of the nucleotide binding pocket. The loop itself is not visible in the structure.
Mutation D41 affects the lip of the nucleotide pocket by causing the substitution of exon 7 alternative exons (light blue). Residue 200,
which is mutated in Mhc5, is also in this general vicinity of the molecule and acts to enhance the effects of hdp2. A mutation in the regu-
latory light chain binding domain at residue 832 (Mhc8) enhances the effects of the hdp2 allele to a lesser extent. Graphic produced in
collaboration with Dr. Ronald Milligan (The Scripps Research Institute) using the Molscript program.
Figure 3. In situ hybridization analysis of Mhc mRNA accumula-
tion in wild-type and D41 Mhc mutant. D41 mutation creates a
splice junction-like sequence resulting in misregulation of alter-
native splicing of the exon 7 series. Probes specific to alternative
versions of exon 7 show that exon 7d is used in wild-type indirect
flight muscles, but replaced with exon 7c in D41. Panels are
brightfield micrographs of parasagittal sections of thoraces (ante-
rior is left, dorsal is up). (A) Wild-type male probed with exon 7c,
showing no hybridization to the indirect flight muscles that com-
prise the bulk of the upper thoracic region. (B) Wild-type male
probed with exon 7d, showing strong hybridization to the indirect
flight muscles. (C) hdp2/Y;D41/Mhc10 males probed with exon 7c,
showing strong hybridization to the indirect flight muscles. (D)
hdp2/Y;D41/Mhc10 males probed with exon 7d showing failure of
the indirect flight muscles to hybridize with this probe.
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We also studied use of the aberrant version of exon 7a in
the D41 mutant. In wild-type embryos, alternative exon 7a
is abundantly expressed in body wall muscles (Zhang and
Bernstein, manuscript in preparation). Our RT-PCR anal-
ysis of RNA from wild-type embryos confirmed that this is
the major exon 7 version used at this stage (16 clones ex-
amined) and showed that exon 7a is incorporated in all re-
verse transcribed mRNAs studied from homozygous D41
embryos (14 clones). The normal splice junction is used in
the mutant. This would result in premature termination of
translation due to the stop codon described above, and ex-
plains the recessive lethality of the mutation. The suppres-
sive effect of the D41 mutation upon the hdp2 phenotype,
however, appears to result from misexpression of exon 7c
in the indirect flight muscles.
Functional and Structural Effects of D Suppressors
We examined the degree of rescue of hdp2 phenotypes by
each suppressor mutation that maps within the head do-
main of MHC. While the suppressed wing position pheno-
type is evident in all hdp2;D/1 males, none can jump or fly
under standard criteria (Prado et al., 1995). We analyzed
the structural effects of the suppressors in hdp2;D/1 males
at light and electron microscopic levels (Fig. 4). In general,
the organization of the six DLMs is restored with similar
efficiency by the four D mutations. However, the e and f
muscles, their posterior region in particular, are still very
sensitive to contraction, and appear grossly abnormal at
3–5 d (Fig. 4, A, E, I, and M).
Wild-type sarcomere structure and length in hdp2 indi-
viduals is recovered to different degrees as a result of each
D mutation. The M line reappears in all four cases but the
sarcomere length is best restored by D41. Organization of
Z bands is better in D1 and D62 than with the other two
alleles (Fig. 4, B, F, J, and N). The number of thick fila-
ments per fibril averages 950 in D45, 830 in D41, 750 in
D62, and 650 in D1. These are 5–35% below normal. In
spite of nearly normal numbers of thick filaments, D41
fibrils appear particularly unstable at the periphery, where
the lattice collapses (Fig. 4 K). These features, and those
reported for second site suppressor D3 (Prado et al.,
1995), point toward differential sensitivity of the center
versus the periphery of the fibril. The arrangement of
thick and thin filaments found in the suppressed condition
include various types of abnormalities, e.g., absence of a
thick filament, excess thin filaments, substitution of thick
by thin filaments, or doublets of thick filaments (Fig. 4, D,
H, L, and P). These perturbations do not induce major de-
fects in the surrounding structure.
We also studied the effects of the D-series suppressors
upon flight muscle function in the absence of hdp2 muta-
tion. The suppressors show dominant effects upon flight
muscle function (Table II). D1 is least disruptive, with
85% of adults flying upward or horizontally, compared
with 90% in wild-type. D62 is most disruptive, with only
16% flying upward or horizontally (Table II). We deter-
mined whether the wild-type Mhc gene could rescue de-
fects in flight ability by crossing each suppressor strain to a
stock containing an Mhc transgene (Cripps et al., 1994).
No rescue was observed (Table II), consistent with our ob-
servation that suppressor alleles produce stable MHC pro-
teins which interfere with myofibril function.
Allelic Interactions and Specificity of
Suppressed Phenotypes
To investigate the unique nature of each suppressor’s ac-
tion, we tested all pairwise combinations of D mutants in a
hdp2 male background. We expect an additive or synergis-
tic effect when two Mhc mutations are suppressed by dif-
ferent mechanisms. If the same mechanism of suppression
is employed by two different suppressors, we expect a phe-
notype similar to that of flies with a single suppressor.
Only combinations over D1 resulted in viable adults, and
the structure of the resulting a or b fiber from their DLMs
is illustrated in Fig. 5. In the three cases of transheterozy-
gotes, muscle structure is closer to normal than in each of
the four independent D mutants. In addition, hdp2;D1/
D41 flies are able to jump while the D/1 mutants are not.
Interestingly, the D1/D62 combination exhibits a high
number of double thick filaments. This abnormal feature
is rarely seen in D1/1 or D62/1 muscles. The synergistic
effects of D1 suppression observed in combination with
each of the other alleles suggests that D1 employs a
unique suppression mechanism compared with the other
D-series Mhc alleles.
Next, we tested whether other Mhc alleles are capable
of suppression of hdp2 phenotypes, either alone or in
combination with D-series suppressors (Table III). Three
point mutations and the H20 deficiency chromosome were
chosen to observe effects of specific amino acid changes
or reduction in MHC levels upon the hdp2 phenotypes.
Homyk and Emerson (1988) had previously described a
negative interaction between two of these alleles (Mhc5
and Mhc8) and hdp2. Our data corroborated that Mhc5 is
lethal in combination with hdp2/Y, but showed a reduced
viability, rather than complete lethality, between Mhc8
and hdp2/Y (Table III). The heldup phenotype was main-
tained in viable organisms in the latter case. This was also
seen for the Mhc6 point mutation and the deficiency chro-
mosome. These results indicate that underexpression of
MHC or non-D point mutations known to cause a domi-
nant flightless phenotype do not suppress the heldup wing
phenotype associated with specific troponin I allele hdp2.
We studied the non-suppressor Mhc point mutants in
more detail in an attempt to clarify their ability or inability
to interact with the hdp2 mutation. Each mutant accumu-
lates substantial levels of MHC in adult thoraces: Mhc5 ho-
mozygotes at 88% of wild-type levels, Mhc6 homozygotes
at nearly 100% (Kronert et al., 1995), and Mhc8/1 (which
is recessive lethal) at 79% (Mogami et al., 1986). Mhc6 is a
point mutation (Arg to His) in the rod of the myosin mole-
cule (Kronert et al., 1995). We determined molecular
defects in the other two mutants by sequencing clones
containing PCR-amplified copies of their Mhc genes. As
suspected, these mutations result from single amino acid
changes. In the case of Mhc5, amino acid 200 is mutated
from a Gly to Asp (resulting from an A to G transition in
exon 4). On the three-dimensional crystal structure, this
residue is located near the base of loop 1 of the molecule,
at the beginning of a long helix that appears to interact
with the bound nucleotide (Fig. 2). Interestingly, the mu-
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Figure 4. Suppression of the troponin
I mutation hdp2 by the D-series Mhc
mutations. D1 (A–D) and D62 (E–H)
affect the actin-binding loop of MHC.
(A) Sagittal, slightly tilted, view of a
hdp2;D1/1 male. Note the almost nor-
mal appearance of DLM fibers a–d but
the collapse of muscles e and f (arrow-
head). (B) Detail of two fibrils. Note
the restoration of the M line in the sar-
comeres. (C) Cross section of a sup-
pressed muscle. m 5 mitochondrion.
(D) Detail of the thick–thin filament
array. Some structural failures such as
the absence of a thick filament (arrow-
head) or an additional thin filament
(arrow) can be identified. (E) Sagittal
view of a hdp2;D62/1 male. Note the
persistence of gross structural defects
on muscles e and f near the posterior
attachment site. (F) Detail of fibrils
showing virtually normal sarcomeres.
(G) Cross section showing a near nor-
mal fibril. The apparent disorganiza-
tion indicated by an arrowhead is an
artifact of preparation, found occasion-
ally in wild-type. (H) Detail of the fila-
ment array. D41 (I–L) and D45 (M–P)
are mutations near the nucleotide en-
try site in MHC. (I) Sagittal view of a
hdp2;D41/1 male. There are persistent
structural defects towards the posterior
side of muscles e and f. (J) Detail of the
fibrils. Note the incomplete definition
of Z and M bands towards the edge of
the fibril (double arrows). (K) Cross
section of fibrils showing the disorga-
nized array at the periphery (star). (L)
Detail of the filament array. Occasion-
ally, thick filaments are absent or a thin
filament substitutes for thick (squares).
(M) Sagittal section of an hdp2;D45/1
male. As with all other suppressors,
gross structural defects persist toward
the posterior site of e and f muscle, al-
though, in this case, d is also visibly af-
fected. (N) Sarcomeres with incom-
plete restoration of Z and M lines. (O)
Cross view of fibrils. (P) Detail of
filament array showing a double thick
filament (square). Bar: (A, E, I, and
M) 330 mm; (B, F, J, and N) 775 nm;
(C, G, K, and O) 430 nm; (D, H, L, and
P) 144 nm.
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tated amino acid in Mhc5 is quite close to residue 261,
which is mutated in suppressor strain D45. The Mhc8 mu-
tation is located in the region that binds regulatory light
chain, at residue 832 (Fig. 2). The C to T mutation in exon
12 results in a change from Tyr to His. This portion of the
molecule is part of the lever arm that is proposed to move
during the myosin power stroke, due to pivoting about a
point near the active site (Holmes, 1997; Dominguez et al.,
1998).
These three Mhc point mutations exhibit very different
effects when tested in combination with the D mutations in
a hdp2 background (Table III). D1 is lethal when over
Mhc5, but viable over the other two Mhc alleles and the
deficiency chromosome (Df(2)H20). In contrast, Mhc8 is
lethal or poorly viable over D41, D45, or D62, but not over
D1. The Mhc6 mutation has no effect on viability in combi-
nation with suppressor mutations or on their ability to sup-
press heldup wing phenotype, except for a reduction in
suppression with the D45 allele.
Finally, we tested the troponin I allele specificity of
heldup wing suppression by D-series mutations. We used
hdp3 or hdp2/hdp3 as alternative backgrounds. The hdp3
point mutation causes abnormal RNA splicing, resulting in
failure of a specific subset of troponin I isoforms to accu-
mulate in the indirect flight muscles (Barbas et al., 1993).
hdp3 mutants display a paucity of thin filaments and se-
verely disrupted myofibrils (Beall and Fyrberg, 1991). We
detected no suppression in hdp3 or hdp2/hdp3 backgrounds,
indicating that D-series alleles suppress a specific molecu-
lar defect in hdp2 mutation.
Taken together, our genetic studies demonstrate that
suppression of the heldup wing phenotype in the hdp2
point mutant can only result from specific modifications of
MHC structure, as opposed to other perturbations in MHC
structure or reductions in myosin concentration. Con-
versely, structural defects in DLMs caused by depletion of
certain troponin I isoforms cannot be suppressed by these
single amino acid changes in MHC.
Discussion
In this paper, we identified an unexpected interrelation-
ship between myosin and troponin I through the use of a
mutational screen for increased muscle function and integ-
rity. We demonstrated that specific mutations in Mhc re-
vert the heldup wings phenotype and muscle degeneration
Figure 5. Double suppressor combina-
tions. Longitudinal (A, C, and E) and
transverse (B, D, and F) views of D1/
D45 (A and B), D1/D41 (C and D) and
D1/D62 (E and F) dorsolongitudinal
muscles in males carrying the hdp2 mu-
tation. Note the improved restoration
of muscle structure in cases of D41 and
D45 combinations with D1 suggesting
independent and additive mechanisms
of suppression. In the case of the D1/
D62 combination, although there is an
additional improvement in the restora-
tion of sarcomere and filament array,
there is a new structural feature: the
frequent assembly of thick filaments in
pairs. Bar: (A, C, and E) 775 nm; (B,
D, and F) 144 nm.
Table II. Flight Ability Is Impaired by the D-series Suppressors 
and this Phenotype Is Not Rescued by an Additional Copy of 
the Mhc Gene
Mhc genotype Number tested
Direction of flight
Up Horizontal Down Not at all
%
1/1 100 87 3 7 3
1/1/1 119 86 8 4 2
D1/1 60 70 15 10 5
D1/1/1 111 82 8 5 5
D41/1 57 32 53 5 10
D41/1/1 120 37 34 8 21
D45/1 90 67 20 3 10
D45/1/1 93 53 22 15 10
D62/1 72 4 12 42 42
D62/1/1 177 4 20 34 42
Mhc5/1 142 14 44 18 24
Mhc5/1/1 167 17 37 23 23
Table III. Interactions Between D Suppressors and other Mhc 
Mutations in hdp2 Males*
Mhc5 Mhc6 Mhc8 1 Df(2)H20
D1 Lethal 1 hdp 1 Viable
D41 hdp 1 Lethal‡ 1 Lethal
D45 hdp 50% hdp Poorly viable 1 Lethal
D62 hdp 1 Lethal‡ 1 Lethal
1 Lethal hdp Poorly viable hdp hdp hdp
Df(2)H20 Viable/ Viable/ Lethal Viable/ Lethal
flightless flightless flightless
*Minimum of 100 offspring per cross were screened.
‡Lethal also in females hdp2/1.
The Journal of Cell Biology, Volume 144, 1999 998
displayed by flies carrying the hdp2 allele of troponin I.
This reversion is allele specific, both for troponin I muta-
tions and mutations in myosin, indicating that our ap-
proach identifies a novel type of functional interaction be-
tween the muscle proteins. Our data demonstrate that
suppressive effects of D-series mutations do not arise sim-
ply from a reduction in myosin. This is based on accumula-
tion of MHC in the mutant lines, as well as the failure of
Mhc null mutations to suppress hdp2.
The role of the amino acid mutated in hdp2 may be in-
ferred from recent structural and functional studies on this
region of the protein in vertebrate troponin I. The hdp2
mutation affects the NH2-terminal a-helical portion of the
protein shown to interact with troponin C (Farah et al.,
1994; Tripet et al., 1997; Leszyk et al., 1998; Vassylyev
et al., 1998). Rabbit skeletal muscle troponin I/troponin
C cocrystal structure shows hydrophobic interactions be-
tween residue 25, which corresponds to the site of hdp2 mu-
tation, and troponin C (Vassylyev et al., 1998). Although
interaction between troponin I and troponin C appeared
stable (Farah et al., 1994), the NH2-terminal fragment is
now proposed to be released upon Ca21 binding to tropo-
nin C (Tripet et al., 1997; Vassylyev et al., 1998). This re-
lease permits binding of an inhibitory domain of troponin I
to troponin C, allowing the tropomyosin strand to move
from its position blocking actin–myosin interaction. A rea-
sonable model for hdp2 defect is that the mutation hastens
release of the a helix at lower Ca21 concentrations, re-
sulting in more ready binding of troponin I’s inhibitory do-
main to troponin C. Unregulated actin–myosin interaction
would result. The hypercontracted sarcomeres and muscle
degeneration observed are consistent with this model (Fig.
1), as is the requirement for thick filaments for the degen-
erative phenotype (Beall and Fyrberg, 1991).
The four suppressor alleles within the Mhc gene may
identify specific molecular interactions between troponin I
and myosin. Direct interaction between the troponin com-
plex and the myosin head in insect flight muscle is structur-
ally feasible, since antibody labeling of troponin com-
plexes show they occur at some sites of rigor crossbridge
attachment (Reedy et al., 1994). Myosin interaction may
occur directly with the wild-type troponin I residue identi-
fied by the hdp2 mutation, perhaps aiding release of the
surrounding a-helical region during Ca21 binding by tro-
ponin C. This would facilitate actomyosin interactions, al-
lowing the thin filament to progress to a fully active state.
When poor regulation occurs in the hdp2 mutant, the sup-
pressor mutation could prevent or alter myosin interaction
with the troponin I molecule. This would decrease the mu-
tant troponin I’s ability to release from troponin C, allow-
ing the blocking action of troponin I on actomyosin in-
teraction to continue at low Ca21 concentrations. More
normal muscle structure and function would result. Thus,
while the troponin I mutation could alter the equilibrium
among the three states of the thin filament proposed by
McKillop and Geeves (1993) and Vibert et al. (1997), this
equilibrium could be reestablished through a compensat-
ing mutation in the myosin head. The observation by Lin et
al. (1996), that troponin mutations can alter cycling of
crossbridges, supports this possibility.
Direct interaction between mutated residues in troponin
I and the myosin head is feasible for the residues identified
by the D62 Mhc mutation. Biochemical (Mornet et al.,
1981; Sutoh, 1982), structural (Rayment et al., 1993a,b),
and chimeric molecule studies (Uyeda et al., 1994; Rovner
et al., 1995) indicate that residues deleted from the actin
binding loop of MHC in mutation D62 normally interact
with the thin filament during the crossbridge cycle. For
suppressor mutation D1, changes in orientation of the ac-
tin-binding loop could result from amino acid alteration at
the loop’s base. Instead of revealing a direct interaction
between troponin I and MHC, D1 or D62 could affect
crossbridge cycling and indirectly compensate for the tro-
ponin I mutation. The mechanism of action of these two
suppressors may be similar. However, the synergistic effect
of D1 when combined with the other D suppressors, and
the peculiar effect of D1 in combination with other Mhc al-
leles (Table III), suggests that this suppressor elicits a dif-
ferent, albeit unknown, functional change.
Direct interaction between the MHC regions identified
by the other two suppressor mutations (D41 and D45) and
troponin I is not as obvious a possibility. However, it is im-
portant to realize that crystal structures of the myosin
head represent static pictures of particular stages of the
mechanochemical cycle. Thus, other contacts between
thick and thin filaments are possible. A more likely expla-
nation involves nucleotide exchange. Since both mutations
are located near the nucleotide entry site of the molecule, it
is reasonable to postulate that they would affect the ATP-
ase cycle by regulating nucleotide entry or exit from the
binding pocket (Murphy and Spudich, 1998; Sweeney et
al., 1998). ADP release is the rate-limiting step in un-
loaded shortening of some muscles (Siemankowski et al.,
1985). If suppressor mutations reduce the rate of ADP
release, myosin’s dissociation from actin, which occurs
upon subsequent binding of ATP, would be inhibited. This
could dampen the unregulated actomyosin interactions
that appear to occur in the hdp2 mutant, since the ability of
the myosin molecule to bind ATP and go through another
step of the mechanochemical cycle would be reduced.
Another consideration for the mechanism of suppres-
sion is that myosin could act through a third protein to reg-
ulate troponin I. In this situation, troponin I would inte-
ract indirectly with myosin, through another protein or
protein complex (such as tropomyosin or other compo-
nents of the troponin complex). When troponin I has an
abnormal interaction with this partner in the hdp2 mutant,
the partner is unable to productively interact with myosin,
unless a specific interacting site (the location of the sup-
pressor mutation) is altered. Actin is an obvious possibility
for such an intermediary protein, since it interacts with the
troponin/tropomyosin complex, as well as with myosin.
A key result of our study is that specific residues on
MHC are required for suppression, suggesting they are
critical to thick–thin filament interactions. None of the
other alleles of Mhc, including point mutations, suppress
the heldup wing phenotype (Table III). This includes a
mutation in the motor domain (Mhc5), a mutation in the
lever arm (Mhc8), and a mutation in the rod (Mhc6). Inter-
estingly, the genotype hdp2;Mhc5/1 results in a lethal in-
teraction (Table III, and Homyk and Emerson, 1988). The
location of this mutation close to the site of nucleotide en-
try/exit, and near D41 and D45 suppressors suggests that
Mhc5 might affect the ATPase cycle in the reverse direc-
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tion of suppressors, thereby exacerbating rather than ame-
liorating the hdp2 phenotypes. Support for this hypothesis
is provided by the observation that lethality, but not heldup
phenotype, of the hdp2;Mhc5/1 genotype is eliminated
when either the D41, D45, or D62 suppressors replace the
wild-type Mhc allele (Table III). D1 is an exception in res-
cuing lethality of the hdp2;Mhc5 combination. In contrast,
MHC of the D1 type is compatible with Mhc8 for viabil-
ity, but this is not so with D41, D45, or D62 (Table III).
The opposite effects of D1 and other suppressor alleles
strengthens our conclusion from suppressor heterozygote
studies that D1 MHC acts to suppress the hdp2 phenotype
by a different mechanism than other suppressors.
Our studies have implications for understanding disease
processes in humans. In familial hypertrophic cardiomyop-
athy, single amino acid changes in a number of contractile
proteins affect crossbridge cycling, resulting in myofibrillar
disarray and hypertrophy (Towbin, 1998; Watkins et al.,
1995). Mutations implicated in this disease include numer-
ous defects in the myosin S1 domain (Rayment et al.,
1995) and in troponin I (Kimura et al., 1997). Thus, muta-
tions in both thick and thin filament components can have
similar consequences upon human cardiac muscle struc-
ture and function. A confounding factor in understanding
the basis of disease process, and predicting its severity, is
that genetic background influences disease penetrance.
Our observations in Drosophila indicate that mutations in
other components of the contractile apparatus can either
exacerbate or ameliorate muscle dysfunction, and could
serve as a model for understanding influences of genetic
background upon disease penetrance. Further, our find-
ings suggest suppression of human diseases by a mutated
version of a contractile protein might prove useful in de-
veloping therapeutic strategies.
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